drugset / Trial / NCT03125629
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This clinical trial studies how well positron emission tomography (PET)/computed tomography (CT) works compared to PET/magnetic resonance imaging (MRI) in evaluating patients with cancer. PET/CT and PET/MRI may determine which scanner is best for the patient's type of cancer and other types of cancers.
Timeline
- Start
- 2014-05-27
- Primary completion
- 2016-11-30
- Completion
- 2020-02-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | F-18 FDG | Diagnostic / imaging agent | — | Intravenous |
| Subject | Ga68-DOTA-TATE | Unknown | — | Intravenous |
Indications
No indication recorded.